(Q51426858)

5 April 2018

title

Serum bone turnover markers may be involved in the metastatic potential of lung cancer patients. (English)

1 reference

5 April 2018

1 reference

Eleni M Karapanagiotou

1

1 reference

5 April 2018

Evangelos Terpos

2

1 reference

5 April 2018

Kalliopi D Dilana

3

1 reference

5 April 2018

Christina Alamara

4

1 reference

5 April 2018

Ioannis Gkiozos

5

1 reference

5 April 2018

Aris Polyzos

6

1 reference

5 April 2018

Kostas N Syrigos

7

1 reference

5 April 2018

publication date

17 April 2009

1 reference

5 April 2018

published in

Medical Oncology

1 reference

5 April 2018

volume

27

1 reference

5 April 2018

issue

2

1 reference

5 April 2018

page(s)

332-338

1 reference

5 April 2018

https://scigraph.springernature.com/pub.10.1007/s12032-009-9214-z

exact match

0 references

cites work

Metastasis to bone: causes, consequences and therapeutic opportunities

1 reference

12 December 2020

The relative use of eight collagenous and noncollagenous markers for diagnosis of skeletal metastases in breast, prostate, or lung cancer patients

1 reference

12 December 2020

Mechanisms of cancer metastasis to the bone

1 reference

12 December 2020

Biochemical markers and skeletal metastases

1 reference

12 December 2020

Osteoprotegerin (OPG)-a potential new role in the regulation of endothelialcell phenotype and tumour angiogenesis?

1 reference

12 December 2020

The Role of osteopontin in lung disease

1 reference

12 December 2020

Bone metastasis. Prognosis, diagnosis and treatment

1 reference

12 December 2020

Elevated serum bone sialoprotein and osteopontin in colon, breast, prostate, and lung cancer.

1 reference

12 December 2020

Osteocalcin: is it a useful marker of bone metastasis and response to treatment in advanced prostate cancer?

1 reference

12 December 2020

Expression of a novel matrix metalloproteinase regulator, RECK, and its clinical significance in resected non-small cell lung cancer

1 reference

12 December 2020

Soluble receptor activator of nuclear factor kappaB ligand-osteoprotegerin ratio predicts survival in multiple myeloma: proposal for a novel prognostic index

1 reference

12 December 2020

Conclusion: Bone markers in metastatic bone disease

1 reference

12 December 2020

Receptor activator of nuclear factor kappaB ligand (RANKL)/osteoprotegerin (OPG) ratio is increased in severe osteolysis

1 reference

12 December 2020

The Role of Whole Body Bone Scan in Bronchogenic Carcinoma

1 reference

12 December 2020

The molecular triad OPG/RANK/RANKL: involvement in the orchestration of pathophysiological bone remodeling

1 reference

12 December 2020

Biochemical approach to the detection and monitoring of metastatic bone disease: What do we know and what questions need answers?

1 reference

12 December 2020

Tartrate-resistant acid phosphatase isoform 5b: a novel serum marker for monitoring bone disease in multiple myeloma

1 reference

12 December 2020

Abnormal bone remodeling process is due to an imbalance in the receptor activator of nuclear factor–κB ligand (RANKL)/osteoprotegerin (OPG) axis in patients with solid tumors metastatic to the skeleton

1 reference

12 December 2020

Comparison of 10 serum bone turnover markers in prostate carcinoma patients with bone metastatic spread: diagnostic and prognostic implications.

1 reference

12 December 2020

MMP expression profiling in recurred stage IB lung cancer

1 reference

12 December 2020

Detection of breast carcinoma metastases in bone: relative merits of X-rays and skeletal scintigraphy

1 reference

12 December 2020

Comparison of bone scintigraphy with bone markers in the diagnosis of bone metastasis in lung carcinoma patients.

1 reference

12 December 2020

Bone sialoprotein is predictive of bone metastases in resectable non-small-cell lung cancer: a retrospective case-control study

1 reference

12 December 2020

Clinical implications of the osteoprotegerin/RANKL/RANK system for bone and vascular diseases.

1 reference

12 December 2020

Diagnostic value of bone and tumour markers in patients with malignant diseases

1 reference

12 December 2020

Markers of bone turnover for the management of patients with bone metastases from prostate cancer

1 reference

12 December 2020

10.1007/S12032-009-9214-Z

Identifiers

DOI

1 reference

5 April 2018

1 reference

5 April 2018